Skip to main content
. Author manuscript; available in PMC: 2020 Aug 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2019 Dec 11;29(2):343–351. doi: 10.1158/1055-9965.EPI-19-0832

Table 4.

Associations of adult height with V metric in the Nurses’ Health Study (NHS) and the NHSII, stratified by menopausal status at mammogram

Beta coefficients (95% confidence intervals)

Premenopausal women (N=1,700)
Postmenopausal women (N=1,947)
N MV-adjusted a N MV-adjusted a
Height, inches

<63.0 294 0 (Ref) 377 0 (Ref)
63.0–64.9 518 0.001 (−0.13, 0.13) 601 0.20 (0.08, 0.32)
65.0–65.9 232 −0.06 (−0.21, 0.10) 278 0.10 (−0.04, 0.24)
66.0–66.9 220 0.001 (−0.16, 0.16) 258 0.13 (−0.01, 0.28)
≥67.0 436 −0.03 (−0.16, 0.11) 433 0.08 (−0.05, 0.21)
P-trend 0.67 0.61
Per 1-inch increase −0.005 (−0.03, 0.02) 0.005 (−0.01, 0.03)
a

MV-adjusted model includes age (years, continuous), race (white/nonwhite), personal history of benign breast disease (yes/no), family history of breast cancer (yes/no), parity/age at first birth (nulliparous, 1–2 births/<25 years, 1–2 births/25–29 years, 1–2 births/≥30 years, >=3 births/<25 years, >=3 births/≥25 years, parous/missing age at first birth), alcohol use (0, 0.1–4.9, 5–14.9, ≥15 g/d, missing), smoking (never, former, current), breastfeeding (<1, 1–6, 7–12, ≥13 months), childhood body fatness (1–4.5+ level, continuous) and, in postmenopausal women, age at menopause (<=44, 45–49, 50–54, ≥55 years, missing) and postmenopausal hormone use (never, former, current).

Note: V measures = V75 erosion, low resolution